As for the status of controlling shareholders, Consew Co., Ltd. holds 24.88% of our voting rights. The company aims to keep personnel, funding, and transactions with related parties as separated as possible, and no related-party transactions occurred during the 35th term. Chairman Emeritus Iijima is also a representative of that company. We plan to continue this policy going forward.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6888","jir_company_name":"Acmos Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-09-16","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/6888-20260916-01.pdf","jir_short_summary":"As for the status of controlling shareholders, Consew Co., Ltd. holds 24.88% of our voting rights. The company aims to keep personnel, funding, and transactions with related parties as separated as possible, and no related-party transactions occurred during the 35th term. Chairman Emeritus Iijima is also a representative of that company. We plan to continue this policy going forward.","jir_summary":"### Overview of controlling shareholder relationships\nThis document discloses matters concerning controlling shareholders, and as of June 30, 2026, Conceive & Eye Co., Ltd. holds 24.88% of Acmos Co., Ltd.'s voting rights. The company engages in investment business as its main line of business, and Acmos is an investee of that company. Chairman of the board, Hideyuki Iijima, also serves as a director of that company, and that company owns 100% of Acmos' issued shares.\n\n### Transaction relationships and policy\nWe make independent decisions in determining business activities and management strategy, and we maintain a policy to minimize personal, funding, and transaction relationships with parent companies or the like. We plan to continue this policy. There are no transactions with controlling shareholders during the 35th term (from July 1, 2025 to June 30, 2026).","jir_financial_highlights":"Share of voting rights owned by controlling shareholder: 24.88\uff05 (Unknown)\nAffiliated company: Conceive & Eye Co., Ltd. (Unknown)","jir_category":"","jir_hashtags":"#AcmosCo.,Ltd., #ControllingShareholder, #Governance, #AffiliatedCompany","jir_key_figures":"Controlling shareholder voting rights: 24.88\uff05\nChairman of the Representative Directors: Hideyuki Iijima (Representative Director of Conceive & Eye Co., Ltd.)\nCoverage period: 35th term (2025\/7\/1\u20132026\/6\/30)","jir_meta_title":"\u3010Acmos\u3011Matters Concerning Controlling Shareholders\uff5cSeptember 16, 2026","jir_meta_description":"Disclosure of Acmos' controlling shareholder information and related policies. Conceive & Eye Co., Ltd. holds 24.88% of voting rights and policy on separation of management control is described. No related-party transactions during the 35th term.","jir_og_title":"Acmos Controlling Shareholder Information\uff5cSeptember 16, 2026","jir_og_description":"Conceive & Eye Co., Ltd. holds 24.88% of voting rights. Policy to maintain management independence and absence of related-party transactions in the 35th term is disclosed.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59843,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"general_ir","footnotes":""},"sector":[],"importance":[],"class_list":["post-114434","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n